Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw an upside of 4.62% to close Monday at $1.02 after adding $0.04 on the day. The 5-day average trading volume is 1,167,500 shares of the company’s common stock. It has gained $1.1000 in the past week and touched a new high 2 times within the past 5 days. An average of 695,270 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 456,456.
TNXP’s 1-month performance is -36.25% or -$0.5800 on its low of $0.9320 reached on 08/07/23. The company’s shares have touched a 52-week low of $0.96 and high of $11.12, with the stock’s rally to the 52-week high happening on 01/13/23. YTD, TNXP has lost -58.13% or -$1.4162 and has reached a new high 8 times. However, the current price is down -90.83% from the 52-week high price.
Valuation Metrics
TNXP stock has a beta of 2.21. Moving on to other valuation ratios, the price-to-book (PB) in the most recent quarter is 0.06.
Tonix Pharmaceuticals Holding Corp.’s quick ratio for the period ended March 30 was 6.40, with the current ratio over the same period at 6.40.
Earnings Surprise
For the quarterly period ending March 30 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 13.29% to -$34.08 million, while revenue of -$28.98 million was 14.96% off the previous quarter. Analysts expected TNXP to announce -$3.03 per share in earnings in its latest quarter, but it posted -$3.25, representing a -7.30% surprise. EBITDA for the quarter stood at more than -$33.01 million. TNXP stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 13.66 million, with total debt at $1.03 million. Shareholders hold equity totaling $10.34 million.
Let’s look briefly at Tonix Pharmaceuticals Holding Corp. (TNXP) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 07 August was 23.28% to suggest the stock is trending oversold, with historical volatility in this time period at 251.79%.
The stock’s 5-day moving average is $1.0070, reflecting a -4.67% or -$0.0500 change from its current price. TNXP is currently trading -40.70% above its 20-day SMA, -75.92% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -42.70% and SMA200 by-67.84%.
Stochastic %K and %D was 4.50% and 2.92% and the average true range (ATR) pointed at 0.1324. The RSI (14) points at 27.10%, while the 14-day stochastic is at 9.69% with the period’s ATR at 0.1354. The stock’s 9-day MACD Oscillator is pointing at -0.1878 and -0.3777 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), Noble Capital Markets launched coverage with an Outperform rating. Analysts offering their rating for TNXP stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate TNXP as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 2 have offered a “buy” rating.
What is TNXP’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $6.50 and a high of $15.00, with their median price target at $8.00. Looking at these predictions, the average price target given by analysts is for Tonix Pharmaceuticals Holding Corp. (TNXP) stock is $9.83.
